Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: DexCom, Dr. Pepper, Aetna, Array BioPharma, ConEd, Williams Companies, Dell, Tech Data, Aventine, Allscripts, Anesiva
Aug 13, 2008 08:28 AM
- Twenty Stocks to Short Sell
Jul 09, 2008 10:31 AM
- NASDAQ Technical Picture - Narrow Range Inside Bar
May 09, 2008 02:54 AM
- UPDATE: Abbott Gets FDA OK For Continuous Glucose Monitor
Mar 13, 2008 12:55 PM
- Abbott Gets FDA Approval For Continuous Glucose Monitor
Mar 13, 2008 08:06 AM
- Abbott Gets FDA Approval For Continuous Glucose Monitor
Mar 13, 2008 08:06 AM
- Earnings Summary: Tuesday, March 11, 2008
Mar 12, 2008 02:49 AM
- DexCom: Court Stays Abbott Labs Patent Infringement Suit
Aug 18, 2006 07:37 AM
- FMR Reports New Passive Stakes In 18 Companies
Aug 10, 2006 05:03 PM
- IVAX Diagnostics Announces Plan to Seek FDA 510(k) Clearance for PARSEC(TM) System and DexCom Granted FCC Waiver
Jan 20, 2006 01:01 PM
- DexComTM Receives CE Mark Approval for the SEVEN® Continuous Glucose Monitoring System
Dec 01, 2008 08:35 AM
- DexCom to Present at the Piper Jaffray 20th Annual Health Care Conference
Nov 24, 2008 04:37 PM
- DexCom To Present at Lazard Capital Markets 5th Annual Healthcare Conference
Nov 11, 2008 07:11 PM
- DexCom to Present at Stephens Inc. Fall Investment Conference
Nov 11, 2008 07:02 PM
- DexCom Inc. Reports Third Quarter 2008 Financial Results
Nov 10, 2008 04:09 PM
- Edwards Lifesciences and DexCom to Develop Continuous Glucose Monitoring Products for Hospital Market
Nov 10, 2008 04:01 PM
- DexCom Schedules Third Quarter 2008 Earnings Release and Conference Call for November 10, 2008
Oct 31, 2008 05:01 PM
- DexCom to Present at the Third Annual JMP Securities Healthcare Focus Conference
Oct 02, 2008 04:07 PM
- JDRF Study Results Show Continuous Glucose Monitoring Provides Significant Benefits in Management of Type 1 Diabetes
Sep 08, 2008 09:22 AM
- DexCom To Present at Canaccord Adams 28th Annual Global Growth Conference
Aug 07, 2008 06:25 PM
- Form 4 ROPER JESS For: Nov 21 (10K)
Nov 24, 2008 08:56 PM
- Form 4 Balo Andrew K For: Nov 21 (10K)
Nov 24, 2008 08:50 PM
- Form 4 GRAHAM CLAUDIA For: Nov 20 (10K)
Nov 24, 2008 08:47 PM
- Form 4 GREGG TERRANCE H For: Nov 20 (10K)
Nov 24, 2008 08:42 PM
- Form 4/A GREGG TERRANCE H For: Nov 19 (10K)
Nov 24, 2008 08:38 PM
- Form 4 MOY JEFFREY For: Nov 19 (10K)
Nov 21, 2008 08:43 PM
- Form 3/A MOY JEFFREY For: Sep 25 (10K)
Nov 21, 2008 08:43 PM
- Form 4 Pacelli Steven Robert For: Nov 19 (10K)
Nov 20, 2008 06:38 PM
- Form 4 GREGG TERRANCE H For: Nov 19 (10K)
Nov 20, 2008 06:35 PM
- Form 4 VALDES JORGE A For: Nov 19 (10K)
Nov 20, 2008 02:29 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
DXCM
|
Compare to S&P
|
| YTD |
-77.35 %
|
-62.89 %
|
| 4 Weeks |
-55.75 %
|
-52.17 %
|
| 12 Weeks |
-70.89 %
|
-59.65 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.17 %
|
|
EPS Growth in Last Year: -25.00 %
|
|
Sales Growth in Last Quarter: -3.13 %
|
|
Sales Growth in Last Quarter: 56.86 %
|
|
|
